Clinical trials
Completed Phase 2 Mesothelioma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 2 |
| 2006 | 5 |
| 2007 | 1 |
| 2009 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 7 |
| 2017 | 2 |
| 2018 | 2 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 36 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 2 |
| National Cancer Institute (NCI) | 2 |
| Novartis Pharmaceuticals | 2 |
| AHS Cancer Control Alberta | 1 |
| Ain Shams University | 1 |
| Andrei Iagaru | 1 |
| Armando Santoro, MD | 1 |
| AstraZeneca | 1 |
| Azienda USL Reggio Emilia - IRCCS | 1 |
| Bayer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mesothelioma | 36 |
| Mesothelioma, Malignant | 12 |
| Lung Neoplasms | 4 |
| Carcinoma, Renal Cell | 3 |
| Breast Neoplasms | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Melanoma | 2 |
| Neoplasms | 2 |
| Osteosarcoma | 2 |
| Uveal Melanoma | 2 |
Trials
Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.